• Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page

Moderna shares slide as longer-term data shows quick fall in RSV vaccine efficacy

Quote
cafead

cafead

Administrator
Staff member
  • cafead   Feb 09, 2024 at 11:22: AM
via Moderna (MRNA.O), shares fell 6% on Friday after a longer-term analysis of a trial indicated a quicker fall in the efficacy of its experimental respiratory syncytial virus (RSV) vaccine.

article source
 




Top Bottom
Back
Quote